Vir Biotechnology (VIR) Other Non-Current Assets (2018 - 2026)

Vir Biotechnology has disclosed Other Non-Current Assets across 9 years of filings, most recently posting $7.0 million for Q1 2026.

• Other Non-Current Assets for Q1 2026 came in at $7.0 million, up 10.89% year-over-year; the trailing twelve-month figure through Mar 2026 was $7.0 million (up 10.89% YoY), and the FY2025 annual result was $7.0 million, down 42.25% from the prior year.
• Other Non-Current Assets came in at $7.0 million for Q1 2026 at Vir Biotechnology, roughly flat from $7.0 million in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $13.2 million in Q2 2025 to a low of $6.3 million in Q1 2025.
• The 5-year median for Other Non-Current Assets is $7.0 million (2026), against an average of $7.6 million.
• Peak annual rise in Other Non-Current Assets reached 107.16% in 2025, while the deepest fall reached 42.25% in 2025.
• Vir Biotechnology's Other Non-Current Assets stood at $6.7 million in 2022, then retreated by 3.12% to $6.4 million in 2023, then jumped by 86.99% to $12.1 million in 2024, then slumped by 42.25% to $7.0 million in 2025, then decreased by 0.1% to $7.0 million in 2026.
• The last three Other Non-Current Assets figures came in at $7.0 million (Q1 2026), $7.0 million (Q4 2025), and $7.0 million (Q3 2025), per Business Quant data.